WAM
ABBV icon

Wernau Asset Management’s AbbVie ABBV Stock Holding History

Wernau Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$273K Buy
1,255
+17
+1% +$3.77K 0.19% 41
2025
Q4 		$283K Buy
1,238
+26
+2% +$5.92K 0.15% 42
2025
Q3 		$281K Hold
1,212
– – 0.19% 43
2025
Q2 		$225K Sell
1,212
-261
-18% -$48.5K 0.16% 43
2025
Q1 		$309K Sell
1,473
-15
-1% -$2.92K 0.24% 43
2024
Q4 		$264K Buy
+1,488
New +$274K 0.2% 44

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wernau Asset Management's ABBV Position: Q1 2026 in Review

Wernau Asset Management increased its AbbVie (ABBV) stake by 1.4% in Q1 2026, buying an estimated $3.77K and bringing the position to 1,255 shares worth $273K. The position accounts for 0.19% of the portfolio, ranked #41.

Wernau Asset Management first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $309K in Q1 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Wernau Asset Management held 1,255 shares of AbbVie worth $273K as of Q1 2026.
  • Wernau Asset Management bought 17 AbbVie shares in Q1 2026, an estimated $3.77K.
  • AbbVie made up 0.19% of Wernau Asset Management's portfolio in Q1 2026, its #41 holding.
  • Wernau Asset Management first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Wernau Asset Management's AbbVie position peaked at $309K in Q1 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Wernau Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.